NFKB1 and melanoma: Similar to other malignant tumours, melanoma resistance to chemotherapy has been attributed to the elevated expression of Mcl‐1, XIAPs, or alterations of NF‐κB whose down‐regulation or inhibition sensitize melanoma cells to anticancer agent‐induced apoptosis 5, 6, 7.